Literature DB >> 25024597

Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Nobuyuki Toshikuni1, Mikihiro Tsutsumi1, Tomiyasu Arisawa1.   

Abstract

Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are serious health problems worldwide. These two diseases have similar pathological spectra, ranging from simple hepatic steatosis to steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Although most subjects with excessive alcohol or food intake experience simple hepatic steatosis, a small percentage of individuals will develop progressive liver disease. Notably, both ALD and NAFLD are frequently accompanied by extrahepatic complications, including cardiovascular disease and malignancy. The survival of patients with ALD and NAFLD depends on various disease-associated conditions. This review delineates the clinical characteristics and outcomes of patients with ALD and NAFLD by comparing their epidemiology, the factors associated with disease susceptibility and progression, and the predictors and characteristics of outcomes. A comprehensive understanding of the characteristics and outcomes of ALD and NAFLD is imperative in the management of these chronic liver diseases.

Entities:  

Keywords:  Alcoholic liver disease; Chronic liver disease; Clinical characteristics; Nonalcoholic fatty liver disease; Outcomes

Mesh:

Year:  2014        PMID: 25024597      PMCID: PMC4093692          DOI: 10.3748/wjg.v20.i26.8393

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  133 in total

1.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 2.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 3.  The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Clin Liver Dis       Date:  2012-06-20       Impact factor: 6.126

4.  Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.

Authors:  Ricard Solà; Marco Antonio Alvarez; Belén Ballesté; Silvia Montoliu; Mònica Rivera; Mireia Miquel; Isabel Cirera; Rosa Maria Morillas; Susanna Coll; Ramon Planas
Journal:  Liver Int       Date:  2006-02       Impact factor: 5.828

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 6.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.

Authors:  H Bell; J Jahnsen; E Kittang; N Raknerud; L Sandvik
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

9.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Authors:  Maria Stepanova; Nila Rafiq; Zobair M Younossi
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

10.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

View more
  40 in total

Review 1.  Prevalence of fatty liver disease and the economy in China: A systematic review.

Authors:  Jin-Zhou Zhu; Qin-Yi Zhou; Yu-Ming Wang; Yi-Ning Dai; Jiang Zhu; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

Review 2.  Evolution of the liver biopsy and its future.

Authors:  Dhanpat Jain; Richard Torres; Romulo Celli; Jeremy Koelmel; Georgia Charkoftaki; Vasilis Vasiliou
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 3.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

4.  Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Authors:  Ali Zarrinpar; Claire M Faltermeier; Vatche G Agopian; Bita V Naini; Michael P Harlander-Locke; Fady M Kaldas; Douglas G Farmer; Ronald W Busuttil
Journal:  Liver Int       Date:  2018-12-02       Impact factor: 5.828

Review 5.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

Review 6.  L-Serine: a Naturally-Occurring Amino Acid with Therapeutic Potential.

Authors:  J S Metcalf; R A Dunlop; J T Powell; S A Banack; P A Cox
Journal:  Neurotox Res       Date:  2017-09-19       Impact factor: 3.911

Review 7.  Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

Authors:  Jin-Zhou Zhu; Yi-Ning Dai; Yu-Ming Wang; Qin-Yi Zhou; Chao-Hui Yu; You-Ming Li
Journal:  Dig Dis Sci       Date:  2015-05-28       Impact factor: 3.199

Review 8.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

9.  Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease.

Authors:  Jillian Price; Carey Escheik; Ali Weinstein; Patrice Winter; Lynn Gerber; Zobair Younossi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-17       Impact factor: 3.738

Review 10.  The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome.

Authors:  Stephen Malnick; Yaakov Maor
Journal:  Visc Med       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.